Jazz Pharmaceuticals JAZZ Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's accounts payable?
- Jazz Pharmaceuticals (JAZZ) reported accounts payable of -$21.4M in Q1 2026.
- How has Jazz Pharmaceuticals's accounts payable changed year-over-year?
- Jazz Pharmaceuticals's accounts payable decreased by 212.0% year-over-year, from $19.1M to -$21.4M.
- What does accounts payable mean?
- The change in the amount the company owes its suppliers for goods and services received.
- How do you interpret accounts payable?
- An increase indicates the company is retaining cash longer by delaying payments, while a decrease suggests faster settlement of obligations.
- How does accounts payable compare across companies?
- Standard metric for assessing working capital management; peers with strong bargaining power often maintain higher payable balances.